Last reviewed · How we verify
Placebo matching OCS capsules — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo matching OCS capsules (Placebo matching OCS capsules) — GlaxoSmithKline. This is a placebo control formulation designed to match the appearance and administration route of an active oral corticosteroid (OCS) comparator in clinical trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo matching OCS capsules TARGET | Placebo matching OCS capsules | GlaxoSmithKline | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo matching OCS capsules CI watch — RSS
- Placebo matching OCS capsules CI watch — Atom
- Placebo matching OCS capsules CI watch — JSON
- Placebo matching OCS capsules alone — RSS
Cite this brief
Drug Landscape (2026). Placebo matching OCS capsules — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-matching-ocs-capsules. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab